Des-Gly9-Oxytocin is an oxytocin analog lacking the terminal glycine residue, leading to altered cyclization behavior and folding characteristics. This structural shift affects conformational stability. Its sequence supports binding-motif investigations. Researchers use it in mechanistic studies of oxytocin variants.
CAT No: O06020
Synonyms/Alias:(S)-2-(((S)-2-(2-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl)-2-oxoacetyl)pyrrolidin-1-yl)amino)-4-methylpentanamide;8-L-Leucinamide-1-8-oxytocin;Oxytocin; 8-leucinamide-9-deglycinamide-
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More